Stay updated on Autologous BCMA CAR T-cells in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page.

Latest updates to the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov revision/version indicator from v3.5.2 to v3.5.3, reflecting a site release rather than updates to the trial record.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded revision entry v3.5.2 and removed revision entry v3.5.0 from the history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the page history.SummaryDifference0.1%

- Check75 days agoChange DetectedNew revision entry v3.4.2 added to the history. Older revision v3.4.1 and a funding-status notice were removed.SummaryDifference0.7%

- Check82 days agoChange DetectedThe history shows a new government-funding notice and an update to the site revision (v3.4.1), replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Autologous BCMA CAR T-cells in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page.